Hotgen

Beijing Hotgen Biotech Co., Ltd. specializes in developing, manufacturing, and selling in-vitro diagnostic (IVD) and point-of-care testing (POCT) products, along with biodefense solutions. The company's IVD offerings include instruments and kits designed to aid in the diagnosis of various health conditions, such as cardiovascular diseases, chronic liver diseases, tumor screening, kidney injuries, rheumatoid arthritis, and infectious diseases. Additionally, Hotgen's biodefense product line addresses threats from bioterrorism and food safety, with tests for agents like Yersinia pestis, Anthrax, and pathogenic bacteria such as E. coli and salmonella. These products are utilized in military operations, customs inspections, disease control centers, and emergency response scenarios. Established in 2005, Hotgen is headquartered in Beijing, China.

Changqing Lin

Chairman and General Manager

1 past transactions

Aorui Bio

Series B in 2022
Aorui Bio is a biotech R&D company that combines whole genome liquid biopsy and ML tech for wireless cancer early screening technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.